CCMINC
JAZZ icon

Cardinal Capital Management Inc (North Carolina)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cardinal Capital Management Inc (North Carolina)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.58M Buy
14,867
+158
+1% +$34.6K 0.43% 73
2026
Q1 		$2.78M Buy
14,709
+171
+1% +$29.9K 0.36% 85
2025
Q4 		$2.47M Buy
14,538
+66
+0.5% +$10.1K 0.33% 89
2025
Q3 		$1.91M Buy
14,472
+475
+3% +$57K 0.26% 100
2025
Q2 		$1.49M Buy
13,997
+743
+6% +$80.7K 0.22% 111
2025
Q1 		$1.65M Buy
13,254
+114
+0.9% +$14.9K 0.25% 103
2024
Q4 		$1.62M Buy
13,140
+641
+5% +$75.5K 0.25% 104
2024
Q3 		$1.39M Buy
12,499
+431
+4% +$47.2K 0.22% 113
2024
Q2 		$1.29M Buy
12,068
+227
+2% +$25K 0.22% 109
2024
Q1 		$1.43M Buy
11,841
+1,611
+16% +$197K 0.23% 105
2023
Q4 		$1.26M Buy
10,230
+246
+2% +$30.7K 0.24% 103
2023
Q3 		$1.29M Buy
9,984
+315
+3% +$42K 0.26% 92
2023
Q2 		$1.2M Buy
9,669
+45
+0.5% +$6.05K 0.24% 99
2023
Q1 		$1.41M Sell
9,624
-66
-0.7% -$9.76K 0.29% 95
2022
Q4 		$1.54M Buy
9,690
+34
+0.4% +$4.98K 0.33% 89
2022
Q3 		$1.29M Sell
9,656
-97
-1% -$14.7K 0.3% 93
2022
Q2 		$1.52M Buy
9,753
+217
+2% +$33.4K 0.35% 84
2022
Q1 		$1.48M Buy
9,536
+404
+4% +$58.6K 0.3% 90
2021
Q4 		$1.16M Buy
9,132
+156
+2% +$20.5K 0.23% 102
2021
Q3 		$1.17M Buy
8,976
+249
+3% +$37.6K 0.25% 98
2021
Q2 		$1.55M Buy
8,727
+2,731
+46% +$473K 0.33% 91
2021
Q1 		$986K Buy
5,996
+115
+2% +$18.9K 0.22% 110
2020
Q4 		$971K Buy
5,881
+375
+7% +$55.9K 0.23% 104
2020
Q3 		$785K Buy
5,506
+1,061
+24% +$132K 0.22% 98
2020
Q2 		$490K Buy
4,445
+2
+0% +$221 0.14% 120
2020
Q1 		$443K Buy
+4,443
New +$574K 0.15% 120

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina)'s JAZZ Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) increased its Jazz Pharmaceuticals (JAZZ) stake by 1.1% in Q2 2026, buying an estimated $34.6K and bringing the position to 14,867 shares worth $3.58M. The position accounts for 0.43% of the portfolio, ranked #73.

Cardinal Capital Management Inc (North Carolina) first reported a position in JAZZ in Q1 2020 and has held it in 26 quarters since. 333 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 14,867 shares of Jazz Pharmaceuticals worth $3.58M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) bought 158 Jazz Pharmaceuticals shares in Q2 2026, an estimated $34.6K.
  • Jazz Pharmaceuticals made up 0.43% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #73 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • 333 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.